Skip to content
Home/Companies/MedTech/Gyros AB

Gyros AB

MedTech·Sweden·Exited 2016·Held 16yr
Entry
2000
Hold
16yr
Exit
2016

Who owns Gyros AB?

Gyros AB is a Swedish MedTech company, now owned by Mesa Laboratories, which acquired it in 2016 from HealthCap.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
HealthCap
Investor
HealthCap
HealthCap (early funds) · 1996 · VC

Key facts

HQSweden
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
Mesa Laboratories
Exit Year
2016

More from HealthCap (early funds)

Other portfolio companies in the same fund.

Affibody AB
Active
BiotechSweden· 2001
Pharmion Corp.
Exited 2003
PharmaUS· 2001
Cytos Biotechnology AG
Exited 2002
BiotechSwitzerland· 1999
Actelion Holding Ltd
Exited 2017
PharmaSwitzerland· 1997
to Johnson & Johnson
Biotage AB (Pyrosequencing AB)
Exited 2000
BiotechSweden· 1997
Carmeda AB
Exited 2005
MedTechSweden· 1996
to W.L. Gore & Associates

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Gyros AB?

Gyros AB is now owned by Mesa Laboratories, which acquired it in 2016 from HealthCap.

When did Mesa Laboratories acquire Gyros AB?

Mesa Laboratories acquired Gyros AB in 2016, buying from HealthCap.

Who did Gyros AB sell to?

HealthCap sold Gyros AB to Mesa Laboratories in 2016 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue